Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
12.24
+0.50 (4.26%)
At close: Apr 28, 2026, 4:00 PM EDT
12.35
+0.11 (0.90%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Schrödinger Revenue
In the year 2025, Schrödinger had annual revenue of $255.87M with 23.29% growth. Schrödinger had revenue of $87.24M in the quarter ending December 31, 2025, a decrease of -1.23%.
Revenue (ttm)
$255.87M
Revenue Growth
+23.29%
P/S Ratio
3.53
Revenue / Employee
$301,022
Employees
850
Market Cap
903.62M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.53B |
| Omnicell | 1.18B |
| Claritev | 965.41M |
| GoodRx Holdings | 796.85M |
| Phreesia | 480.59M |
| Certara | 418.84M |
| HealthStream | 304.06M |
| Omada Health | 260.21M |
SDGR News
- 7 days ago - Schrödinger to Announce First Quarter 2026 Financial Results on May 5 - Business Wire
- 11 days ago - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Schrödinger Transcript: 2026 KeyBanc Capital Markets Healthcare Forum - Transcripts
- 7 weeks ago - Schrödinger Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Schrödinger Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Schrödinger Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results - Business Wire
- 2 months ago - Schrödinger to Participate in Upcoming Investor Conferences - Business Wire